A blood test for small molecules abnormally expressed in pancreatic cancer may be a promising route to early detection of the disease, researchers at The University of Texas MD Anderson Cancer Center report in the September edition of the journal Cancer Prevention Research.
Blood test for small molecules abnormally expressed in pancreatic cancer may be a promising route to early detection of the disease